324 related articles for article (PubMed ID: 37762557)
21. Increased Expression of the NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome in Dermatomyositis and Polymyositis is a Potential Contributor to Their Pathogenesis.
Yin X; Han GC; Jiang XW; Shi Q; Pu CQ
Chin Med J (Engl); 2016 May; 129(9):1047-52. PubMed ID: 27098789
[TBL] [Abstract][Full Text] [Related]
22. Endometrial inflammasome activation accompanies menstruation and may have implications for systemic inflammatory events of the menstrual cycle.
Azlan A; Salamonsen LA; Hutchison J; Evans J
Hum Reprod; 2020 Jun; 35(6):1363-1376. PubMed ID: 32488243
[TBL] [Abstract][Full Text] [Related]
23. [Inhibitory effect and mechanism of deoxyschizandrin on NLRP3 inflammasome].
Cui HR; Li PY; Li YM; Wang RL; He JJ; Sang XX; Cai GM; Niu M; Wang JB; Bai ZF; Xiao XH
Yao Xue Xue Bao; 2017 Jan; 52(1):80-5. PubMed ID: 29911779
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid.
Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G
J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093
[TBL] [Abstract][Full Text] [Related]
25. Dental Calculus Stimulates Interleukin-1β Secretion by Activating NLRP3 Inflammasome in Human and Mouse Phagocytes.
Montenegro Raudales JL; Yoshimura A; Sm Z; Kaneko T; Ozaki Y; Ukai T; Miyazaki T; Latz E; Hara Y
PLoS One; 2016; 11(9):e0162865. PubMed ID: 27632566
[TBL] [Abstract][Full Text] [Related]
26. Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells.
Hu Y; Wu D; Feng X; Shi Z
Genes Genomics; 2022 Sep; 44(9):1117-1124. PubMed ID: 33909229
[TBL] [Abstract][Full Text] [Related]
27. A C-type lectin induces NLRP3 inflammasome activation via TLR4 interaction in human peripheral blood mononuclear cells.
Ikenohuchi YJ; Silva MDS; Rego CMA; Francisco AF; da Silva Setúbal S; Ferreira E Ferreira AA; Boeno CN; Santana HM; Felipin KP; de Lima AM; de Mattos Fontes MR; Paloschi MV; Soares AM; Zuliani JP
Cell Mol Life Sci; 2023 Jun; 80(7):188. PubMed ID: 37349530
[TBL] [Abstract][Full Text] [Related]
28. LncRNA CRNDE Exacerbates IgA Nephropathy Progression by Promoting NLRP3 Inflammasome Activation in Macrophages.
Shen M; Pan X; Gao Y; Ye H; Zhang J; Chen Y; Pan M; Huang W; Xu X; Zhao Y; Jin L
Immunol Invest; 2022 Jul; 51(5):1515-1527. PubMed ID: 34747317
[TBL] [Abstract][Full Text] [Related]
29. NOD-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Activation Exacerbates 5-Fluorouracil-Induced Small Intestinal Mucositis via Interleukin-1β Activation.
Nakata A; Nadatani Y; Watanabe T; Matsumoto Y; Kosaka S; Higashimori A; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Tanigawa T; Fujiwara Y
Digestion; 2021; 102(2):298-312. PubMed ID: 31846964
[TBL] [Abstract][Full Text] [Related]
30. Activation of the NLRP3 inflammasome and elevation of interleukin-1β secretion in infection by sever fever with thrombocytopenia syndrome virus.
Li Z; Hu J; Bao C; Gao C; Zhang N; Cardona CJ; Xing Z
Sci Rep; 2022 Feb; 12(1):2573. PubMed ID: 35173184
[TBL] [Abstract][Full Text] [Related]
31. KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle-Wells syndrome.
Kaneko N; Kurata M; Yamamoto T; Shigemura T; Agematsu K; Yamazaki T; Takeda H; Sawasaki T; Koga T; Kawakami A; Yachie A; Migita K; Yoshiura KI; Urano T; Masumoto J
Sci Rep; 2020 Aug; 10(1):13562. PubMed ID: 32782316
[TBL] [Abstract][Full Text] [Related]
32. Downregulated NLRP3 and NLRP1 inflammasomes signaling pathways in the development and progression of type 1 diabetes mellitus.
Liu H; Xu R; Kong Q; Liu J; Yu Z; Zhao C
Biomed Pharmacother; 2017 Oct; 94():619-626. PubMed ID: 28783585
[TBL] [Abstract][Full Text] [Related]
33. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
[TBL] [Abstract][Full Text] [Related]
34. miR-1290 modulates the radioresistance of triple-negative breast cancer by targeting NLRP3-mediated pyroptosis.
Li Y; Li X
Clin Transl Oncol; 2022 Sep; 24(9):1764-1775. PubMed ID: 35471684
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion.
Ho SC; Chang YH
Molecules; 2018 Feb; 23(2):. PubMed ID: 29466287
[TBL] [Abstract][Full Text] [Related]
36. NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis.
Kim SK; Cho YJ; Choe JY
Clin Chim Acta; 2018 Nov; 486():269-274. PubMed ID: 30138619
[TBL] [Abstract][Full Text] [Related]
37. MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants.
Schuh E; Groß CJ; Wagner D; Schlüter M; Groß O; Kümpfel T
Clin Immunol; 2019 Jun; 203():45-52. PubMed ID: 30974290
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
39. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
Chen L; Huang CF; Li YC; Deng WW; Mao L; Wu L; Zhang WF; Zhang L; Sun ZJ
Cell Mol Life Sci; 2018 Jun; 75(11):2045-2058. PubMed ID: 29184980
[TBL] [Abstract][Full Text] [Related]
40. Effect of lysed and non-lysed sickle red cells on the activation of NLRP3 inflammasome and LTB4 production by mononuclear cells.
Pitanga TN; Santana SS; Zanette DL; Guarda CC; Santiago RP; Maffili VV; Lima JB; Carvalho GQ; Filho JR; Ferreira JRD; Aleluia MM; Nascimento VML; Carvalho MOS; Lyra IM; Borges VM; Oliveira RR; Goncalves MS
Inflamm Res; 2021 Jul; 70(7):823-834. PubMed ID: 34196737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
